In reality, the production did not have permission to paint directly on the reservoir wall
The decision to terminate the clinical development of Lotiglipron was based on the pharmacokinetic data from the clinical Phase 1 drug-drug interaction studies (NCT05671653 and NCT05788328), as well as the laboratory measurements of elevated transaminases in these Phase 1 studies and the ongoing Phase 2 study (NCT05579977)
On The Pen obtained a copy of that email, which raises additional concerns about ProRxs licensing status and its relationship with PerfectRx/SmartScripts, a 503A pharmacy that, under federal law, is not supposed to be producing drugs for office use in bulk the way a 503B outsourcing facility like ProRx would
The results are there, and the weight loss is fantastic
COA provided on every lot
The TrimRx Difference What sets our platform apart is the fusion of clinical expertise with a focus on the patient experience